pbpk modelling to predict drug-biologic interactions with cytokine modulators
Published 1 year ago • 330 plays • Length 55:43Download video MP4
Download video MP3
Similar videos
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
50:40
application of pbpk modeling in predicting p-glycoprotein-mediated drug-drug interactions
-
55:39
a best practice framework for applying pbpk modeling to pediatric drug development
-
1:13:05
pbpk modelling to predict salt form advantage when dosed with acid-reducing agents
-
59:17
applications of pbpk modelling for regulatory submissions: case studies
-
22:49
setting up a therapeutic protein pbpk model in simcyp simulator: key considerations
-
46:25
developing a pbpk model for high lipophilic zwitterionic drugs to predict food effect
-
53:31
simcyp in vitro analysis (siva) toolkit: get the most from your in vitro data
-
1:02:16
leveraging dermal pbpk modeling and simulation approaches
-
13:20
developing compound files for pbpk modeling in the simcyp simulator
-
40:57
precision dosing using pbpk modeling
-
50:49
pbpk modeling and simulation for regulatory decision making: impact on us prescribing information
-
1:01:14
pbpk modeling & simulation to support asciminib nda submission and inform drug product label
-
36:08
pbpk modeling of antibody-drug conjugates – concept and application
-
1:02:46
solving a mystery using pbpk: how drug-excipient complexes can confound a metabolic ddi result
-
1:52
pbpk modeling supports approval of breakthrough cancer drug
-
3:39
common myths about pbpk modeling and simulation- busted!
-
57:56
pbpk models for mabs in paediatrics and pregnancy – current status, opportunities and challenges
-
58:36
pbpk for the pill an approach to assess the risk benefit of drugs
-
1:06:27
the importance of pbpk model validation and reproducibility in obstetric pharmacology
-
1:05:52
application of physiologically-based pharmacokinetics (pbpk) to personalized dosing
-
14:14
certara's simcyp simulator demo